GPS Wealth Strategies Group LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GPS Wealth Strategies Group LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,485 shares of the medical equipment provider’s stock after acquiring an additional 178 shares during the quarter. GPS Wealth Strategies Group LLC’s holdings in Intuitive Surgical were worth $661,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ISRG. Provence Wealth Management Group purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $276,000. Public Employees Retirement System of Ohio increased its stake in shares of Intuitive Surgical by 5.4% in the fourth quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock worth $64,531,000 after buying an additional 9,869 shares during the period. HCR Wealth Advisors raised its holdings in Intuitive Surgical by 26.3% during the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 217 shares during the last quarter. Kades & Cheifetz LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $230,000. Finally, Checchi Capital Advisers LLC grew its holdings in Intuitive Surgical by 2.5% in the 4th quarter. Checchi Capital Advisers LLC now owns 2,875 shares of the medical equipment provider’s stock worth $970,000 after acquiring an additional 70 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Craig H. Barratt sold 2,496 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $402.89, for a total value of $1,005,613.44. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 2,496 shares of the business’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $402.89, for a total value of $1,005,613.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,372 shares of company stock valued at $6,667,430. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Trading Up 0.4 %

ISRG stock traded up $1.98 on Wednesday, hitting $471.21. The company had a trading volume of 1,105,703 shares, compared to its average volume of 1,558,113. The stock has a market cap of $167.14 billion, a price-to-earnings ratio of 84.70, a P/E/G ratio of 4.97 and a beta of 1.39. The stock’s 50-day simple moving average is $439.66 and its 200 day simple moving average is $405.79. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $473.75.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. During the same period last year, the firm posted $1.18 earnings per share. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on ISRG shares. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. JPMorgan Chase & Co. lifted their price target on shares of Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Evercore ISI decreased their price objective on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a report on Friday, July 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the company from $380.00 to $510.00 in a research note on Friday, August 2nd. Finally, Truist Financial increased their price target on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $442.30.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.